EPS (Diluted) for Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's current diluted EPS (TTM) is $9.05. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$9.05
YoY change
+13.8%
5Y CAGR
-3.6%
Peak year (2021)
$15.53
Latest annual
$8.75
EPS (Diluted) history chart for Quest Diagnostics (DGX) from 1996 to 2025
EPS (Diluted) history table for Quest Diagnostics (DGX) from 1996 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $8.75 | +13.8% | ||
| 2024 | $7.69 | +2.3% | ||
| 2023 | $7.52 | -5.8% | ||
| 2022 | $7.98 | -48.6% | ||
| 2021 | $15.53 | +47.6% | ||
| 2020 | $10.52 | +67.2% | ||
| 2019 | $6.29 | +18.9% | ||
| 2018 | $5.29 | -3.8% | ||
| 2017 | $5.50 | +22.0% | ||
| 2016 | $4.51 | -7.4% | ||
| 2015 | $4.87 | +27.8% | ||
| 2014 | $3.81 | -31.2% | ||
| 2013 | $5.54 | +60.1% | ||
| 2012 | $3.46 | +18.5% | ||
| 2011 | $2.92 | -27.9% | ||
| 2010 | $4.05 | +4.7% | ||
| 2009 | $3.87 | +30.3% | ||
| 2008 | $2.97 | +70.7% | ||
| 2007 | $1.74 | -40.8% | ||
| 2006 | $2.94 | +10.5% | ||
| 2005 | $2.66 | +13.2% | ||
| 2004 | $2.35 | +16.3% | ||
| 2003 | $2.02 | +24.7% | ||
| 2002 | $1.62 | +95.2% | ||
| 2001 | $0.83 | +53.7% | ||
| 2000 | $0.54 | -2260.0% | ||
| 1999 | $-0.03 | -111.4% | ||
| 1998 | $0.22 | -215.8% | ||
| 1997 | $-0.19 | -96.4% | ||
| 1996 | $-5.33 | — |
EPS (Diluted) values are taken from Quest Diagnostics's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Quest Diagnostics (DGX) reported diluted EPS of $8.75 – grew 13.8% year-over-year.
Quest Diagnostics diluted EPS has grown for 2 consecutive years, with a -3.6% compound annual growth rate over 2020–2025 (5 years).
Between 2021 and 2025, Quest Diagnostics diluted EPS plunged 43.7%, falling from $15.53 to $8.75.
The dataset's maximum diluted EPS sits at $15.53 (2021); the minimum reading of $-5.33 dates to 1996.
Among 8 Healthcare peers, Quest Diagnostics (DGX) ranks 7th; the peer median for diluted EPS is $13.16.
Quest Diagnostics EPS (Diluted) by Year
Quest Diagnostics EPS (Diluted) 2025: $8.75
Quest Diagnostics diluted EPS in 2025 was $8.75, grew 13.8% from 2024.
Quest Diagnostics EPS (Diluted) 2024: $7.69
Quest Diagnostics diluted EPS in 2024 was $7.69, edged up 2.3% from 2023.
Quest Diagnostics EPS (Diluted) 2023: $7.52
Quest Diagnostics diluted EPS in 2023 was $7.52, declined 5.8% below 2022.
Quest Diagnostics EPS (Diluted) 2022: $7.98
Quest Diagnostics diluted EPS in 2022 was $7.98, plunged 48.6% below 2021.
Quest Diagnostics EPS (Diluted) 2021: $15.53
Quest Diagnostics diluted EPS in 2021 was $15.53.
See more financial history for Quest Diagnostics (DGX).
Sector peers — EPS (Diluted)
Companies in the same sector as Quest Diagnostics, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Quest Diagnostics's diluted EPS?
- Latest reported diluted EPS for Quest Diagnostics (DGX) is $9.05 (period ending March 31, 2026).
How has Quest Diagnostics diluted EPS changed year-over-year?
- Quest Diagnostics (DGX) diluted EPS changed +13.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Quest Diagnostics diluted EPS?
- Quest Diagnostics (DGX) diluted EPS compound annual growth rate is -3.6% over the most recent 5 years available.
When did Quest Diagnostics diluted EPS hit its highest annual value?
- Quest Diagnostics diluted EPS reached its highest annual value of $15.53 in 2021.
What was Quest Diagnostics diluted EPS in 2024?
- Quest Diagnostics (DGX) diluted EPS in 2024 was $7.69.
What was Quest Diagnostics diluted EPS in 2025?
- Quest Diagnostics (DGX) diluted EPS in 2025 was $8.75.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DGX Overview
Company profile, financial tools, and key metrics
DGX Revenue Counter
Earns $357.62 every second. See per minute, hour, and day.
DGX Earnings Counter
Earns $32.47 per second net profit. See per minute, hour, and day.
DGX Economic Scale
Exceeds Monaco's GDP. Compare with world economies.
DGX What If Invested
What if you had invested $1,000? See historical returns from any date.
DGX How It Makes Money
Discover visual breakdown of $11.28B in revenue — where it comes from and where it goes.
DGX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DGX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DGX Daily Price Character
Steady · 50.6% historical win rate (green days). Streaks & record days.
DGX Buybacks
2.09% TTM buyback yield. Shareholder yield & SBC comparison.
DGX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
DGX Dividend Profile
Yield: 1.72%. Safety: 5/8. See full history.
DGX Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
DGX Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.